4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic
A new research report from the analysts at UBS focuses on four companies that stand to benefit from rising demand for the drugs they produce that treat hepatitis C.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 278Ebola Stock Short Interest Surprise
Some Ebola-related stocks had been heavily shorted as they were considered by many investors as the next would-be stock bubble from a major news event.
Gilead Sees Large Insider Stock Sale Into Debt Offering
A Gilead Sciences bond offering and a key insider stock sale netting over $14 million should be considered by investors.
Biotech Short Interest Becomes Stock Specific (Updated)
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies, such as Ebola-vaccine companies.
New Cancer Detection Technique Has Enormous Potential for Life Science Stocks
A new report from Cowen makes the case that a blood test that detects evidence of cancer in the circulation could soon replace the older more traditional biopsy methods.
The Shame and Lessons of a Dendreon Bankruptcy
Dendreon has committed the ultimate sin by filing for bankruptcy protection.
Humana Earnings Hit by High Drug Costs; Guidance Won’t Cheer Investors Either
Humana reported disappointing third-quarter 2014 results before markets opened Friday morning.
Inotek Pharma Files for IPO
Inotek Pharmaceuticals Corp. has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.
Key Analyst Sees Upside in Medical Devices After Midterm Elections
Oppenheimer has released its list of potential post-election winners in the medical device industry.
Credit Suisse Sees $70 Billion Biosimilars Land Grab
Credit Suisse released its first edition of the "Credit Suisse Biosimilars 101" series of notes, offering analysis and impact of biosimilars.
MannKind Spending Trends See Improvements
MannKind reported its third-quarter financial results on Monday morning.
Is Geron Back From the Dead?
The FDA gave Geron some good news Monday morning when it removed the clinical hold on the its investigational new drug application for imetelstat.
Aegerion Pharmaceuticals Plunges to New 52-Week Low
In the wake of a reported net loss on disappointing sales of its lead product, Aegerion Pharmaceuticals shares lost a third of their value.
Lakeland Living Up to Production Promises
Lakeland.comLakeland Industries Inc. (NASDAQ: LAKE) gave an update Thursday on its business activity in the wake of the Ebola crisis. Globally the two top-selling protective suits for Lakeland are the ChemMax and the MicroMax.…
Top Health Care and Biotech Stocks to Buy That Have Already Posted Earnings
A new research note from Cowen focuses on health care companies that have released earnings and offer investors reasons to own the stocks.